News Conference News ACC 2025 SOUL: Oral Semaglutide Bests Usual Care in High-Risk Type 2 Diabetes Michael O'Riordan March 29, 2025
News Conference News ACC 2024 Interatrial Shunt Falls Short in Sham-Controlled RELIEVE-HF Michael O'Riordan April 06, 2024
News Conference News ACC 2023 Too Many HF Patients Exiting Rural Hospitals Miss Out on Endorsed Therapies Caitlin E. Cox February 23, 2023
News Conference News ACC 2022 METEORIC-HF: Omecamtiv Mecarbil Doesn’t Boost Exercise Capacity in HFrEF Todd Neale April 08, 2022
News Conference News ACC 2022 New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More Shelley Wood April 01, 2022
News Conference News ACC 2019 Final MOMENTUM 3 Results Secure Superiority Claim for HeartMate 3 LVAD Shelley Wood March 22, 2019
News Conference News ACC 2018 Newest HeartMate 3 LV Assist Device Slashes Thrombosis, Reoperation Rates in Advanced HF: MOMENTUM 3 Shelley Wood March 16, 2018
News Conference News ACC 2016 Hints of What’s to Come in New Coronary Revascularization AUC Caitlin E. Cox April 12, 2016
News Conference News ACC 2015 Small Study Suggests Benefits of Denervation for Pulmonary Arterial Hypertension Todd Neale March 17, 2015
News Conference News ACC 2015 ERICCA: Remote Ischemic Preconditioning Fails to Improve Long-Term Outcomes After CABG Yael L. Maxwell March 16, 2015
News Conference News ACC 2014 Intramyocardial Injection of Stem Cells Shows Promise for Severe Ischemic Heart Failure Yael L. Maxwell March 31, 2014